National Medicines Symposium 2024 speakers (L to R): Steve Waller, Professor Jennifer Martin, Professor Libby Roughead, Tegan Taylor[/caption]
This CPD activity is sponsored by Reckitt. All content is the true, accurate and independent opinion of the speakers and the views expressed are entirely their own.[/caption]
Case scenario
Carol, a 67-year-old woman, presents to your pharmacy, tells you that she has not been very active since the coronavirus lockdown and that it’s nice to get outside the house. You screen her for osteoporosis using the Know Your Bones tool and find that she has a medium risk of fracture. You suggest she visits her GP for a formal assessment.
Learning objectivesAfter reading this article, pharmacists should be able to: • Identify patients at risk of osteoporosis
Competency standards (2016) addressed: 1.1, 1.4, 1.5, 1.6, 2.1, 2.3, 3.1, 3.2 |
Already read the CPD in the journal? Scroll to the bottom to SUBMIT ANSWERS.
Introduction
In 2012, 4.74 million Australians over the age of 50 years (66%) had poor bone health including more than one million with osteoporosis.1 The prevalence of osteoporosis is increasing due to Australia’s ageing population.
Over 80% of individuals presenting with fractures arising from minimal trauma (i.e. a fall from a standing height or less) are NOT followed up with appropriate testing, nor prescribed appropriate medications.1 Even when treatment is initiated the outcomes are less than optimal; observational data of Australian PBS and MBS data provide strong eviden
THIS IS A CPD ARTICLE. YOU NEED TO BE A PSA MEMBER AND LOGGED IN TO READ MORE.
